« Back to Record
Citation APA

Machiels, J. P., Boegner, P., Brohée, D., Quanter, D., Louviaux, I., Sautois, B., Whenham, N., Berchem, G., Vanderschueren, B., Fontaine, C., Schmitz, S., Vanmaanen, A., Gillain, A., Schoonjans, J., Rottey, S., Vandenbulcke, J. M., Filleul, B., Seront, E., Henry, S., D'Hondt, L., Lonchay, C., & Holbrechts, S. (2016). Randomized phase II study of cabazitaxel versus methotrexate in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based therapy. The oncologist, 21(12), 1416e8-1416e17. doi:10.1634/theoncologist.2016-0296


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/247272

Machiels, J. P., Boegner, P., Brohée, D., Quanter, D., Louviaux, I., Sautois, B., Whenham, N., Berchem, G., Vanderschueren, B., Fontaine, C., Schmitz, S., Vanmaanen, A., Gillain, A., Schoonjans, J., Rottey, S., Vandenbulcke, J. M., Filleul, B., Seront, E., Henry, S., D'Hondt, L., Lonchay, C., & Holbrechts, S. (2016). Randomized phase II study of cabazitaxel versus methotrexate in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based therapy. The oncologist, 21(12), 1416e8-1416e17. doi:10.1634/theoncologist.2016-0296